Edith M Williams1, Megan Penfield2, Diane Kamen3, James C Oates4. 1. Institute for Partnerships to Eliminate Health Disparities, Arnold School of Public Health, University of South Carolina, 220 Stoneridge Drive, Suite 208, Columbia, SC 29210. 2. Institutional Assessment and Compliance, University of South Carolina, 1710 College Street, Suite 205, Columbia, SC 29208. 3. Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 816, Charleston, SC 29425. 4. Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 816, Charleston, SC 29425; Medical Service, Ralph H. Johnson VA Medical Center, Charleston, SC.
Abstract
OBJECTIVE: Very little is known about the impact of psychosocial stress on African American lupus patients. Due to the exposure of African Americans to a unique trajectory of stressors throughout life, it may be critical to understand the relationship between psychosocial stress and underlying biological mechanisms that influence disease activity and pathology in this high risk group. METHODS: The Balancing Lupus Experiences with Stress Strategies (BLESS) study piloted the validated "Better Choices, Better Health" Chronic Disease Self-Management Program (CDSMP) in 30 African-American lupus patients participating in the SLE Clinic Database Project at the Medical University of South Carolina (MUSC). Measures of psychosocial and biological indicators of stress were collected in all of the patients in each of the study conditions before and after intervention activities, as well as four months post-intervention, to assess the effectiveness of the program in reducing perceived and biological indicators of stress. RESULTS: Participation in the workshops had large effects upon depression (d=1.63 and d = 1.68), social/role activities limitations (d =1.15), health distress (d =1.13 and d = 0.78), fatigue (d =1.03), pain (d =0.96), and lupus self-efficacy (d =0.85). Neither the differences in cortisol or DHEA levels pre- and post-intervention were found to be significantly different between intervention participants and controls. CONCLUSION: The intervention workshops acted to reduce perceived stress and improve quality of life. Our findings imply that comparable, if not more significant gains in relevant health indicators are possible in African American patients when provided the opportunity to participate in CDSMP's.
OBJECTIVE: Very little is known about the impact of psychosocial stress on African American lupuspatients. Due to the exposure of African Americans to a unique trajectory of stressors throughout life, it may be critical to understand the relationship between psychosocial stress and underlying biological mechanisms that influence disease activity and pathology in this high risk group. METHODS: The Balancing Lupus Experiences with Stress Strategies (BLESS) study piloted the validated "Better Choices, Better Health" Chronic Disease Self-Management Program (CDSMP) in 30 African-American lupuspatients participating in the SLE Clinic Database Project at the Medical University of South Carolina (MUSC). Measures of psychosocial and biological indicators of stress were collected in all of the patients in each of the study conditions before and after intervention activities, as well as four months post-intervention, to assess the effectiveness of the program in reducing perceived and biological indicators of stress. RESULTS: Participation in the workshops had large effects upon depression (d=1.63 and d = 1.68), social/role activities limitations (d =1.15), health distress (d =1.13 and d = 0.78), fatigue (d =1.03), pain (d =0.96), and lupus self-efficacy (d =0.85). Neither the differences in cortisol or DHEA levels pre- and post-intervention were found to be significantly different between intervention participants and controls. CONCLUSION: The intervention workshops acted to reduce perceived stress and improve quality of life. Our findings imply that comparable, if not more significant gains in relevant health indicators are possible in African American patients when provided the opportunity to participate in CDSMP's.
Authors: K R Lorig; D S Sobel; A L Stewart; B W Brown; A Bandura; P Ritter; V M Gonzalez; D D Laurent; H R Holman Journal: Med Care Date: 1999-01 Impact factor: 2.983
Authors: Daniel J Birmingham; H N Nagaraja; Brad H Rovin; Lacramioara Spetie; Yanxing Zhao; Xiaobai Li; Kevin V Hackshaw; C Yung Yu; William B Malarkey; Lee A Hebert Journal: Arthritis Rheum Date: 2006-10
Authors: Marc R Blackman; Ranganath Muniyappa; Mildred Wilson; Barbara E Moquin; Howard L Baldwin; Kelli A Wong; Christopher Snyder; Michael Magalnick; Shaan Alli; James Reynolds; Seth M Steinberg; Raphaela Goldbach-Mansky Journal: Arthritis Res Ther Date: 2007 Impact factor: 5.156
Authors: Edith M Williams; J Madison Hyer; Ramakrishnan Viswanathan; Trevor D Faith; Leonard Egede; Jim C Oates; Gailen D Marshall Journal: Hum Immunol Date: 2017-07-14 Impact factor: 2.850
Authors: Edith M Williams; J Madison Hyer; Ramakrishnan Viswanathan; Trevor D Faith; Delia Voronca; Mulugeta Gebregziabher; Jim C Oates; Leonard Egede Journal: Arthritis Care Res (Hoboken) Date: 2018-04-18 Impact factor: 4.794
Authors: Ashley A White; Aissatou Ba; Trevor Daniel Faith; Viswanathan Ramakrishnan; Clara L Dismuke-Greer; Jim C Oates; Edith Marie Williams Journal: Lupus Sci Med Date: 2021-05
Authors: Erica C Spears; Amani M Allen; Kara W Chung; Connor D Martz; Evelyn A Hunter; Thomas E Fuller-Rowell; S Sam Lim; Christina Drenkard; David H Chae Journal: J Behav Med Date: 2021-06-22